APA引文

Lin, Y., Liu, Y., & Shih, J. (2019). The Impact of Clinical Factors, ALK Fusion Variants, and BIM Polymorphism on Crizotinib-Treated Advanced EML4–ALK Rearranged Non-small Cell Lung Cancer. Front Oncol.

Citação norma Chicago

Lin, Yen-Ting, Yi-Nan Liu, and Jin-Yuan Shih. "The Impact of Clinical Factors, ALK Fusion Variants, and BIM Polymorphism On Crizotinib-Treated Advanced EML4–ALK Rearranged Non-small Cell Lung Cancer." Front Oncol 2019.

MLA引文

Lin, Yen-Ting, Yi-Nan Liu, and Jin-Yuan Shih. "The Impact of Clinical Factors, ALK Fusion Variants, and BIM Polymorphism On Crizotinib-Treated Advanced EML4–ALK Rearranged Non-small Cell Lung Cancer." Front Oncol 2019.